Weighing the value of completion nodal dissection for melanoma

Jason B. Liu*, Karl Y. Bilimoria

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations


In the United States, approximately half of patients with a positive sentinel lymph node biopsy undergo a completion lymphadenectomy. Because of the equivocal survival benefits in pursuing a completion lymphadenectomy in these patients, surgeons must weigh the postoperative morbidity of the operation with concerns facing a patient's quality of life and risk of tumor recurrence. We discuss the value of a completion lymphadenectomy in light of the uncertainties facing this management strategy for melanoma. J. Surg. Oncol. 2016;114:281–287.

Original languageEnglish (US)
Pages (from-to)281-287
Number of pages7
JournalJournal of surgical oncology
Issue number3
StatePublished - Sep 1 2016


  • lymphadenectomy
  • melanoma
  • sentinel lymph node
  • value

ASJC Scopus subject areas

  • Surgery
  • Oncology

Fingerprint Dive into the research topics of 'Weighing the value of completion nodal dissection for melanoma'. Together they form a unique fingerprint.

Cite this